Open AccessAn Extremely Different Dysmetabolic Profile Between the Two Available Nonnucleoside Reverse Transcriptase Inhibitors: Efavirenz and Nevirapine
Author(s) -
Roberto Manfredi,
Leonardo Calza,
Francesco Chiodo
Publication year - 2005
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/01.qai.0000143037.70120.fc
Subject(s) - nevirapine , efavirenz , reverse transcriptase , reverse transcriptase inhibitor , virology , medicine , pharmacology , human immunodeficiency virus (hiv) , biology , genetics , viral load , polymerase chain reaction , antiretroviral therapy , gene